Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects

被引:0
|
作者
Sanchez, L. M. Fernandes [1 ]
Lopes, A. A. [2 ]
Santos, A. B. Freitas Rodrigues [3 ]
Silva, B. Costa de Carvalho [4 ]
Mendes, C. P. [5 ]
da Rocha, I. B. Pereira [6 ]
Costa, J. Z. [7 ]
Machado, J. S. [8 ]
de Barros, J. Camargo [9 ]
Cruz, M. E. Mendes [10 ]
Pimentel, S. D. [11 ]
机构
[1] Mt Sinai Hosp, New York, NY USA
[2] Christus Univ Ctr, Fortaleza, Brazil
[3] Univ Med Uninassau Boa Viagem, Recife, Brazil
[4] Pernambuco Fac Hlth, Recife, PE, Brazil
[5] Univ Potiguar, Natal, Brazil
[6] Univ Cuiaba, Cuiaba, Brazil
[7] Univ Fed Santa Catarina, Florianopolis, Brazil
[8] Univ Mogi das Cruzes, Sao Paulo, Brazil
[9] Sao Camilo Univ Ctr, Sao Paulo, Brazil
[10] Juazeiro Norte Med Coll, Natal, Brazil
[11] Petropolis Med Univ, Petropolis, Brazil
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
69
引用
收藏
页码:S344 / S344
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of tofacitinib for treatment of alopecia areata in children: A systematic review and meta-analysis
    Behrangi, Elham
    Barough, Mahdieh Shokrollahi
    Khoramdad, Malihe
    Hejazi, Pardis
    Koltapeh, Masoud Pourghahramani
    Goodarzi, Azadeh
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (12) : 6644 - 6652
  • [22] JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 324 - 325
  • [23] Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials
    Effing, Sophie Marie Anne
    Gyawali, Bishal
    ECLINICALMEDICINE, 2020, 25
  • [24] Use of Mesh in Laparoscopic Paraesophageal Hernia Repair: A Meta-Analysis and Risk-Benefit Analysis
    Mueller-Stich, Beat P.
    Kenngott, Hannes G.
    Gondan, Matthias
    Stock, Christian
    Linke, Georg R.
    Fritz, Franziska
    Nickel, Felix
    Diener, Markus K.
    Gutt, Carsten N.
    Wente, Moritz
    Buechler, Markus W.
    Fischer, Lars
    PLOS ONE, 2015, 10 (10):
  • [25] Uncertain Risk-Benefit Ratio of Metformin Meta-analysis of Effectiveness in Diabetes therapy
    Jecht, M.
    DIABETOLOGE, 2012, 8 (07): : 579 - 580
  • [26] Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis
    Ma, Chenhang
    Liu, Mengyao
    Cheng, Yang
    Wang, Xinchang
    Zhao, Yu
    Wang, Kailu
    Wang, Weijie
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] MAJOR ADVERSE CARDIAC EVENTS AND VENOUS THROMBOEMBOLISM RISK WITH JAK INHIBITORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Maqsood, Muhammad Haisum
    Ottensoser, Molly
    Berger, Jeffrey S.
    Bangalore, Sripal
    Garshick, Michael Seth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1796 - 1796
  • [28] Treatment with Oral Janus Kinase Inhibitors in Adults Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
    Lima Fonseca Rodrigues, Amanda Cyntia
    Madeira, Thiago Magalhaes
    Soares Pessoa, Beatriz Mella
    Castro Olyntho, Marco Antonio, Jr.
    Daum, Nils
    Faria Navarro, Julia Souto
    Nogueira, Bernardo Vieira
    Teixeira, Izabela da Mata
    Lai, Stefanie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB242 - AB242
  • [29] JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
    Russell, Mark D.
    Stovin, Christopher
    Alveyn, Edward
    Adeyemi, Olukemi
    Chan, Chun Kit David
    Patel, Vishit
    Adas, Maryam A.
    Atzeni, Fabiola
    Ng, Kenrick K. H.
    Rutherford, Andrew, I
    Norton, Sam
    Cope, Andrew P.
    Galloway, James B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08) : 1059 - 1067
  • [30] The efficacy and safety of JAK inhibitors for atopic dermatitis: a systematic review and meta-analysis
    Miao, Mengyu
    Ma, Lei
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 1869 - 1877